Stay updated on Pembro/Carbo/Taxol in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembro/Carbo/Taxol in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembro/Carbo/Taxol in Endometrial Cancer Clinical Trial page
- ChecktodayChange DetectedA banner announcing NIH terminology changes and linking to transition updates and FAQs was removed. The study page continues to show a 403 Forbidden error.SummaryDifference1%

- Check7 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0, while the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedA site-wide banner announces NIH website transition updates and says that some NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check21 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study content with an access-denied message while the basic site chrome remains visible. This indicates the record is not accessible at this time.SummaryDifference20%

Stay in the know with updates to Pembro/Carbo/Taxol in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro/Carbo/Taxol in Endometrial Cancer Clinical Trial page.